Compare MPTI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPTI | ORGO |
|---|---|---|
| Founded | 1965 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.9M | 348.6M |
| IPO Year | 2022 | 2016 |
| Metric | MPTI | ORGO |
|---|---|---|
| Price | $72.60 | $2.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $71.00 | $8.50 |
| AVG Volume (30 Days) | 62.7K | ★ 1.3M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ 2.62 | N/A |
| Revenue | $54,417,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $12.15 | $26.27 |
| P/E Ratio | $29.41 | ★ N/A |
| Revenue Growth | 11.03 | ★ 17.04 |
| 52 Week Low | $36.38 | $2.04 |
| 52 Week High | $87.23 | $7.08 |
| Indicator | MPTI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 56.80 | 46.72 |
| Support Level | $60.13 | $2.26 |
| Resistance Level | $79.58 | $2.63 |
| Average True Range (ATR) | 4.06 | 0.16 |
| MACD | 1.23 | 0.01 |
| Stochastic Oscillator | 50.16 | 54.35 |
M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.